DeepOncology AI utilizes deep learning techniques in the fields of radiology and oncology to facilitate clinical cancer research and diagnosis. The company addresses the critical need for automated analysis tools to screen for liver metastases using 3D imaging. The integration of oncology, artificial intelligence, and computer vision has led to technology for the visual detection of liver cancer, one of the deadliest cancer types. DeepOncology AI's DeepOn device offers prospects for precise tumor characterization and early diagnosis and treatment. DeepOncology's express goal is to act as a facilitator between imaging science and clinical research, integrating oncology, radiology, artificial intelligence, and computer vision in clinically significant imaging applications. Through professional, empirical research the company aims to aid in the fight against cancer, where the result of a day's work is wholly tangible and of direct benefit to people's lives.